Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleOriginal ResearchA

Patients’ Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies

Roberta E. Goldman, Donna R. Parker, Charles B. Eaton, Jeffrey M. Borkan, Robert Gramling, Rebecca T. Cover and David K. Ahern
The Annals of Family Medicine May 2006, 4 (3) 205-212; DOI: https://doi.org/10.1370/afm.534
Roberta E. Goldman
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donna R. Parker
ScD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles B. Eaton
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey M. Borkan
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Gramling
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca T. Cover
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David K. Ahern
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Additional Files
    • View popup
    Table 1.

    Participants’ Perceptions of Cholesterol

    CharacteristicPerception
    What it isGoop
    Liquid
    Concentrated fats
    Saturated fats
    Where it isFat in the blood
    Fat in your veins
    Fats in foods
    What it is associated withSteaks
    Pork
    Butter
    Lard
    Overweight
    What puts you at riskFatty foods
    Impure foods
    Too little exercise
    Heredity
    Overweight
    What it doesClogs arteries
    Clogs veins
    Causes heart attacks and strokes
    • View popup
    Table 2.

    Participants’ Representative Reactions to a Strategy for Communicating Cardiovascular Risk-Adjusted Age

    Concerns
    You’ve got to look at other things that most people won’t look at. Is this clinical information, or is this statistical information? Have they actually ran these people through a series of physical tests to come up with these numbers? Or are they just drawing these numbers from medical records?
    But you know, you’ve got to keep in mind that it may not be accurate. So you could be reading something on there. And when you walk in to see your physician, he can tell you something a little different. Something like that would make the person probably be concerned. So when he walks in there, now his blood pressure is up. I’m concerned about the numbers that this computer is going to show you which may not be accurate. It might give you a heart attack. You know.
    I’m thinking that it’s kind of overwhelming. It’s intimidating for a man to come in who is 52 and find out he’s got a heart age of 79. I think it’s gonna be very upsetting. He’s gonna be really shaken.
    Participant 1: It’s like he has one foot in the grave.
    Participant 2: Because he’s 50 years old. And you’re saying his heart age is 72. You know? That’s … he’s almost done with life.
    Participant 3: It is definitely scary. He needs to discuss the problem with his doctor immediately.
    I think it’s going to be startling to a lot of people. A lot of people will say, yeah, I’m 52; I feel like I’m 60. But when people see figures on a computer that’s supposed to be accurate, they’re going to say I’m 52, and I’ve got a heart of a 72 year old man, I think they’re going to be in shock. Nobody wants to hear the truth.
    Participant 1: So maybe you need a transition slide that says how can I improve this or what can I do.
    Participant 2: So they don’t walk away quaking.
    Benefits
    That [cardiovascular risk-adjusted age strategy] is easy, I can understand that. Yeah, that spells everything out. You can go to the doctor a year later, and boom [see how the calculated age has changed].
    No, you ain’t gonna forget that [the age]. Those numbers [actual age and cardiovascular risk-adjusted age] are a hell of a lot easier than the first 3 you plugged in there, the HDL, whatever the heck that is.
    I think the idea of [cardiovascular risk-adjusted age] made it personal. Because this is your age. It brought you into it. The other [probability estimate bar chart], I mean, that’s just another graph. It’s too statistical.
    I think the point is to wake up. I don’t think anyone’s gonna pass out from seeing that [cardiovascular risk-adjusted age]. If something is wrong you need to change the way you’re living.
    I think the average person looking at that [cardiovascular risk-adjusted age] is going to get depressed. And after they get depressed, they’re probably going to reevaluate their life. I mean that’s very revealing.
    Your [cardiovascular risk-adjusted age] is telling you there’s something medically going on. And you need to make some more changes.

Additional Files

  • Tables
  • Supplemental Appendix and Table

    Supplemental Appendix 1. Focus Group Question Guide; Supplemental Table 1. Characteristics of Participants of 7 Focus Groups (FG) (N = 50)

    Files in this Data Supplement:

    • Supplemental data: Appendix 1 - PDF file, 4 pages, 120 KB
    • Supplemental data: Table 1 - PDF file, 1 page, 87 KB
  • The Article in Brief

    Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies

    Roberta E. Goldman, PhD, and colleagues

    Background High cholesterol levels can contribute to cardiovascular (heart) disease, the leading cause of death in the United States. This study uses focus groups to explore people's knowledge of and attitudes toward cholesterol and the risk of cardiovascular disease, as well as their reactions to different methods of communicating the risk of cardiovascular disease.

    What This Study Found All participants were aware that high cholesterol levels can harm health, but few were knowledgeable about hypercholesterolemia (high blood cholesterol level) or the risk of cardiovascular disease associated with it. Most participants did not know their own cholesterol numbers and did not think that knowing their numbers would motivate them to change their health habits. Many assumed they had been tested and their cholesterol levels were healthy, even if their physicians had not mentioned it. Participants felt that a communication method that told them their "heart age" was clear and easy to remember, and might motivate people to make healthful changes. (Heart age considers how your cholesterol levels, family health history, and certain aspects of your personal health history affect your risk of having a heart attack. Based on this information, you are assigned a heart age, which may be higher or lower than your actual age.)

    Implications

    • Complex explanations about cholesterol and cardiovascular disease risk do not appear to be effective in motivating patients to change their health habits. Patients prefer individualized, personally meaningful information that can help them make health care and lifestyle decisions.
    • Providing patients with information they can identify with about their personal risk of cardiovascular disease related to cholesterol may help them to understand and make use of other, more general cholesterol education programs.
  • Annals Journal Club Selections:

    May/June 2006

    The Annals Journal Club is designed to encourage a learning community of those seeking to improve health care and health through enhanced primary care. Additional information is available on the Journal Club home page.

    Articles for Discussion

    • Frich JC, Ose L, Malterud K, Fugelli P. Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study. Ann Fam Med. 2006;4:198-204.
    • Goldman RE, Parker D, Eaton C, et al. Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med. 2006;4:205-212.

    Discussion Tips

    Both journal club articles in this issue are qualitative research studies. Qualitative research involves methods that are particularly strong for discerning meaning and context from the perspective of the study group. Weaknesses of qualitative methods often relate to the degree of transparency of the analysis, the sampling of participants, and the transportability of the findings to other settings.1

    Discussion Questions

    1. Why is an understanding of patients� risk perception important?
    2. What are the strengths and weaknesses of the focus group study design (Goldman) versus the use of depth interviews (Frich)? How might the findings be different if the study questions were asked by surveys? What biases are apparent in the way the data were collected?
    3. How transparent does the analysis appear for both studies? Would the results be as trustworthy if the analyses were conducted by an individual rather than a team?
    4. How does the way the participants were selected affect your interpretation of the findings?
    5. In qualitative research, the term �saturation� is used to indicate that a sufficient sample has been achieved such that new participants contribute relatively little new information. Do these studies� claims of having reached saturation convince you that the important domains of information have been uncovered?
    6. What are the main findings of each study? How do the two studies inform each other?
    7. How transportable are the findings to other settings (particularly to yours)?
    8. What are the studies� implications for how clinicians should talk (or listen) to patients regarding risk and risk perception?
    9. With the much-vaunted advent of �personalized medicine�2,3 based on genetic information, how will patients and clinicians reach a shared understanding of familial risk and personal vulnerability to heritable illness? How can the studies' findings help clinicians and patients communicate about inherited disease risk?
    10. What do these studies say about the whole idea of (genomically) �personalized medicine� and how it might or might not be feasible and ethical in practice?
    11. What are the implications for training clinicians and educating patients?
    12. What are the policy implications of these findings, eg for reimbursement for primary care visits?
    13. To explore the HeartAge calculator, visit www.heartage.com.

    References

    1. Crabtree BF, Miller WL, eds. Doing Qualitative Research. 2nd ed. Newbury Park, California: Sage Publications; 1999.
    2. Snyderman R, Langheier J. Prospective health care: the second transformation of medicine. Genome Biol. 2006;7:104. Epub 2006 Feb 27.
    3. Langreth R, Waldholz M. New era of personalized medicine: targeting drugs for each unique genetic profile. Oncologist. 1999;4:426-427.
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 4 (3)
The Annals of Family Medicine: 4 (3)
Vol. 4, Issue 3
1 May 2006
  • Table of Contents
  • Index by author
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Patients’ Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
19 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Patients’ Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies
Roberta E. Goldman, Donna R. Parker, Charles B. Eaton, Jeffrey M. Borkan, Robert Gramling, Rebecca T. Cover, David K. Ahern
The Annals of Family Medicine May 2006, 4 (3) 205-212; DOI: 10.1370/afm.534

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Patients’ Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies
Roberta E. Goldman, Donna R. Parker, Charles B. Eaton, Jeffrey M. Borkan, Robert Gramling, Rebecca T. Cover, David K. Ahern
The Annals of Family Medicine May 2006, 4 (3) 205-212; DOI: 10.1370/afm.534
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • CORRECTION
  • PubMed
  • Google Scholar

Cited By...

  • Cardiovascular disease risk communication in NHS Health Checks: a qualitative video-stimulated recall interview study with practitioners
  • Patient beliefs and attitudes to taking statins: systematic review of qualitative studies
  • Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
  • Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype
  • Age-dependent prognostic value of exercise capacity and derivation of fitness-associated biologic age
  • Evolution of lipid management guidelines: Evidence might set you free
  • Patient Perceptions of Osteoporosis Treatment Thresholds
  • Translating Cholesterol Guidelines Into Primary Care Practice: A Multimodal Cluster Randomized Trial
  • Risk Stratification for Arrhythmic Sudden Cardiac Death: Identifying the Roadblocks
  • Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile
  • Understanding Uncertainty
  • Absolute Cardiovascular Disease Risk and Shared Decision Making in Primary Care: A Randomized Controlled Trial
  • Patients Prefer Pictures to Numbers to Express Cardiovascular Benefit From Treatment
  • On TRACK: Medical Research Must Consider Context and Complexity
  • Annals Journal Club: A RADICAL Approach
  • In This Issue: Communication in the Era of 'Personalized' Medicine
  • Google Scholar

More in this TOC Section

  • Performance-Based Reimbursement, Illegitimate Tasks, Moral Distress, and Quality Care in Primary Care: A Mediation Model of Longitudinal Data
  • Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease
  • Family-Based Interventions to Promote Weight Management in Adults: Results From a Cluster Randomized Controlled Trial in India
Show more Original Research

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
    • Health promotion
  • Methods:
    • Qualitative methods
  • Other topics:
    • Education
    • Health informatics
    • Communication / decision making
    • Patient perspectives

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine